Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/1999
03/02/1999US5877293 CDR grafted anti-CEA antibodies and their production
03/02/1999US5877285 Lymphocyte specific chemokines; for diagnostic kits; antiproliferative agents; anticancer agents; autoimmune disorders
03/02/1999US5877281 Since del-1 is expressed in endothelial cells and certain cancer cells, it may be useful as an endothelial cell and tumor marker. in addition, the ability of del-1 protein to inhibit vascular formation provides for its use as an
03/02/1999US5877273 Antigenic polypeptide mycobacteria; for production of antibodies; for simple diagnosis of tuberculosis and leprosy
03/02/1999US5877203 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
03/02/1999US5877179 Cystic fibrosis
03/02/1999US5877029 Using antibody against insulin-like growth factor
03/02/1999US5877028 Immunochromatographic assay device
03/02/1999US5877027 Decomposing a natural quartz powder with hydrofluoric acid, evaporating to dryness, heating the residue with a salt or hydroxide of an alkali metal to effect fusion, dissolving in an acid solution and analyzing quantitatively
03/02/1999US5877025 Glycated proteins assay
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999US5877015 APP770 mutant in alzheimer's disease
03/02/1999US5877007 Method of screening for protein inhibitors and activators
03/02/1999US5876997 Phytase
03/02/1999US5876978 Concurrent amplification of target and control cdna in presence of mutant competitive templates, comparing relative band densities; for analysis of small specimens
03/02/1999US5876973 Method for making antibodies which specifically bind to glial growth factors
03/02/1999US5876972 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
03/02/1999US5876970 Expressing and recovering recombinantly produced surfactant protein-c, treating with activated derivative of fatty acid, thus forming fatty acid thioesters at cysteine residues; for stable, nonaggregating therapy for premature infants
03/02/1999US5876967 Fibroblast growth factor homologous factor-2 and methods of use
03/02/1999US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle
03/02/1999US5876963 Human nucleotide pyrophosphohydrolase
03/02/1999US5876958 Assays of cells expressing human calcium channels containing α1 β subunits
03/02/1999US5876957 Accurately applying predetermined amount of indicator system and oxidase or peroxidase to substrate and test pad using nozzle and attached flexible restrictor
03/02/1999US5876955 Endotoxin stabilizing agent, endotoxin composition and method for assaying endotoxin
03/02/1999US5876954 Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification
03/02/1999US5876950 Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy
03/02/1999US5876948 Screening methods to identify neurotoxin inhibitors
03/02/1999US5876947 Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
03/02/1999US5876946 High-throughput assay
03/02/1999US5876945 Immunoassay using reporter linked antibody against processed d1 polypeptide important in photosynthesis to detect enzymatic activity; low signal is indicator of enzyme inhibitor
03/02/1999US5876944 Method for amplification of the response signal in a sandwich immunoassay
03/02/1999US5876943 Antigenic polypeptide produced by genetic engineering for use in diagnosis of and vaccines to peptic ulcers and stomach cancer
03/02/1999US5876936 Nucleic acid sequencing with solid phase capturable terminators
03/02/1999US5876935 Analyte detection for whole blood using heterogenous immunoassay; complexing analyte with first binding reagent labeled with aequorin and second reagent immobilized to magnetic spheres; activating luminescence
03/02/1999US5876932 Method for gene expression analysis
03/02/1999US5876931 Identification of genes
03/02/1999US5876928 Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
03/02/1999US5876925 Generating bacteriophage display library expressing heterologous protein which bonds antigen on magnetically labeled cells; incubating with labeled and unlabeled cells, separating out label cells, isolating dna
03/02/1999US5876920 Screening for vircides and viral suppressors by contacting infected cell with agent, determining if suppression of prenylation of proteins; against hepatitis virus
03/02/1999US5876732 Envelope protein
03/02/1999US5876731 Candidate vaccines against hiv-1 and which are useful in diagnostic application.
03/02/1999US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
03/02/1999US5876718 Using antibodies which bind to protein
03/02/1999US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/02/1999US5876694 Azavesamicols
03/02/1999US5876671 Sonication standard laboratory module
03/02/1999US5876605 Preparation of plasma or serum sample from whole blood
03/02/1999US5876593 Magnetic immobilization and manipulation of biological entities
03/02/1999US5875768 Method and arrangement for determining the sensitivity of a hydrocarbon sensor for an internal combustion engine
03/02/1999CA2246191A1 Method of checking the slump of a ready-mix concrete load
03/02/1999CA2242315A1 Mecb
03/02/1999CA2242252A1 Dexb
03/02/1999CA2241417A1 Novel ffh
03/02/1999CA2214461A1 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53
03/02/1999CA2069772C A device for the safe removal of blood from a supply vessel
03/02/1999CA2058769C Methods for determining phospholipids and antibodies thereof
03/02/1999CA1340413C Method of preparing phosphodiester conjugates useful for immunoactive liposomes
03/01/1999CA2242311A1 Novel compounds
02/1999
02/28/1999CA2245016A1 On-line rheometer device
02/28/1999CA2241427A1 Novel pyrr homolog
02/28/1999CA2241424A1 Novel ftsy
02/28/1999CA2241420A1 Novel folc
02/28/1999CA2241400A1 Ftsy
02/27/1999CA2233681A1 Novel div1b
02/26/1999CA2241431A1 Novel spoiiie
02/26/1999CA2241410A1 Pth
02/25/1999WO1999009455A1 Multi parameter scanner
02/25/1999WO1999009417A2 Method of drug selection
02/25/1999WO1999009416A2 Method of drug selection
02/25/1999WO1999009415A1 Scintillation proximity test
02/25/1999WO1999009414A1 Use of recombinant envelope proteins for diagnosing the dengue virus
02/25/1999WO1999009413A1 Anti-tryptase detection as a diagnostic for inflammatory diseases
02/25/1999WO1999009412A1 Functional fragments of hiv-1 vpr protein and methods of using the same
02/25/1999WO1999009411A1 NOVEL COMPOUND 2-AMINO-3-[2-(α-MANNOPYRANOSYL)INDOL-3-YL]PROPIONIC ACID, PROCESS FOR PREPARING THE SAME, AND METHOD FOR INSPECTING FUNCTION OF LIVING BODY WITH THE NOVEL COMPOUND
02/25/1999WO1999009410A2 Rapid assay for simultaneous detection and differentiation of antibodies to hiv
02/25/1999WO1999009409A1 Housing for a flammable gas detector
02/25/1999WO1999009394A1 Apparatus for performing assays at reaction sites
02/25/1999WO1999009390A1 A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method
02/25/1999WO1999009388A2 Method and apparatus for real time gas analysis and medical fluids monitoring
02/25/1999WO1999009217A1 Methods and compositions for detection or quantification of nucleic acid species
02/25/1999WO1999009210A2 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
02/25/1999WO1999009208A1 Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
02/25/1999WO1999009206A1 Methods for using granzymes and binding molecules thereof for treating diseases characterized by abnormal apoptosis
02/25/1999WO1999009204A1 Methods for the high-resolution identification of solvent-accessible amide hydrogens in polypeptides
02/25/1999WO1999009203A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes
02/25/1999WO1999009201A2 Biosensor with immobilized bioluminescent microorganisms
02/25/1999WO1999009199A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
02/25/1999WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999WO1999009179A2 Antigen constructs useful in the detection and differentiation of antibodies to hiv
02/25/1999WO1999009177A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
02/25/1999WO1999009176A1 Neisseria lactoferrin binding protein
02/25/1999WO1999009172A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses
02/25/1999WO1999009166A2 Prostate tumor polynucleotide and antigen compositions
02/25/1999WO1999009165A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009156A2 Protease-related protein
02/25/1999WO1999009155A1 70 human secreted proteins
02/25/1999WO1999009149A1 Three-dimensional polymer matrices
02/25/1999WO1999009148A1 Crystals of hepatitis c virus helicase or fragments thereof comprising a helicase binding pocket
02/25/1999WO1999009146A1 Human serum inducible kinase (snk)